Trefoil Therapeutics

Developer protein engineering drugs to treat corneal endothelial diseases

placeSan Diego, California, United States calendar_todayFounded 2014 groups10 employees language trefoiltherapeutics.com

Innovation

7 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 485 times.

YearFilings
20151
20161
20172
20181
20193
20202
20213
20221
20234
20244
20253
20261

Investor mix

10 investors on record; lead investors include Hatteras Venture Partners, Bios Partners.

Investor typeCountShare
Venture capital880%
Other / undisclosed220%
Coming soon